No Word Yet On Supreme Court’s Plans For Gene Patent Case
This article was originally published in The Gray Sheet
Executive Summary
Association for Molecular Pathology v. Myriad Genetics Inc., a closely watched case on the question of whether human genes are patentable, was noticeably absent from the court’s Feb. 21 list of orders, despite a pending petition for judicial review.